Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01467557 · ClinicalTrials.gov registry record
Daily Disposable Performance of 1•DAY ACUVUE® TruEye™ and 1•DAY ACUVUE® MOIST® With LACREON® TECHNOLOGY
A clinical trial, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- 1,171
- Enrollment target
NCT01467557: Completed study, sponsored by Johnson & Johnson Vision Care.
NCT01467557 is a clinical trial that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 1,171 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01467557 has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- 1,171 participants
- Enrollment target
Study Summary
This study is an observational registry of patients who have recently been prescribed 1•DAY ACUVUE® TruEye® or 1•DAY ACUVUE® MOIST® Brand Contact Lenses with LACREON® TECHNOLOGY.
Primary Outcome
Adverse events were reported by subjects via the electronic surveys if they responded "yes" to the question "Since we last contacted you, have you experienced a red or painful eye that required a visit to an eye doctor or emergency room?". Consensus diagnosis was made after review of clinical records by Adjudication Panel.
Interventions
- DEVICE narafilcon B daily disposable soft contact lenses
- DEVICE etafilcon A daily disposable soft contact lenses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,171 participants |
| Start Date | 2011-10 |
| Est. Completion | 2013-10 |
What the finished NCT01467557 record still lists
NCT01467557 is an observational study that tracks outcomes without assigning an intervention. Its 1,171 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 2 interventions - of which narafilcon B daily disposable soft contact lenses is the first listed.
NCT01467557 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01467557 about?
NCT01467557 is a clinical study titled "Daily Disposable Performance of 1•DAY ACUVUE® TruEye™ and 1•DAY ACUVUE® MOIST® With LACREON® TECHNOLOGY". This study is an observational registry of patients who have recently been prescribed 1•DAY ACUVUE® TruEye® or 1•DAY ACUVUE® MOIST® Brand Contact Lenses with LACREON® TECHNOLOGY.
What is the current status of trial NCT01467557?
This trial is currently completed. The enrollment target is 1,171 participants. The study started on 2011-10. Estimated completion is 2013-10.
What interventions are being tested in trial NCT01467557?
The interventions under investigation include: narafilcon B daily disposable soft contact lenses (DEVICE), etafilcon A daily disposable soft contact lenses (DEVICE).
Who is sponsoring clinical trial NCT01467557?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06469788 · 1,170 participants · NA
Testimonials and Navigation in Rheumatology
- NCT04275557 · 1,174 participants
Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas
- NCT06133322 · 1,176 participants · NA
Blood Pressure Lowering Strategies to Eliminate Hypertension Disparities (BLESSED)
- NCT07009509 · 1,166 participants · NA
Pilot Study of the YES-CAN! Program to Prevent Youth Nicotine Vaping
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia